Search results
Showing 3196 to 3210 of 8905 results
Early value assessment (EVA) guidance on artificial intelligence (AI) technologies for assessing and triaging skin lesions referred to the urgent suspected skin cancer pathway.
Details of the business expenses incurred by the board and senior management team in delivery of their duties.
Our board has 2 sub-committees: the audit and risk assurance committee and the remuneration committee.
Our board sets out our strategic priorities and policies. It has 2 sub-committees, the audit and risk assurance committee and the remuneration committee.
Surgery for vaginal vault prolapse Patient decision aid ? 1 c NICE 2019. All rights reserved. Subject to Notice of rights. Last updated April 2019....
Day-to-day decision making is the responsibility of NICE's executive team.
A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal
Digital self-help for eating disorders: early value assessment (HTG768)
Early value assessment (EVA) guidance on digital self-help for eating disorders.
Tools for building or evaluating a medtech evidence base with NICE
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
Our methods and processes (health technology evaluation manual)
NICE's technology appraisal and highly specialised technologies guidance manual
Early value assessment (EVA) guidance on digital technologies for managing mild to moderate symptoms of hip or knee osteoarthritis.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Consultation on changes to technology appraisals and highly specialised technologies
Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual) Methods and...
Home About us Our board Public board meetings...